Shree Ganesh Remedies Ltd
BSE:540737
Shree Ganesh Remedies Ltd
BSE:540737
Price:
475.2
INR
0.48%
Market Closed
Market Cap:
₹6.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shree Ganesh Remedies Ltd
BSE:540737
|
IN |
|
A
|
Alufluoride Ltd
BSE:524634
|
IN |
|
R
|
Rianlon Corp
SZSE:300596
|
CN |
|
Y
|
Yuken India Ltd
NSE:YUKEN
|
IN |
|
M
|
Malaysia Building Society Bhd
KLSE:MBSB
|
MY |
|
S
|
Sichuan Baicha Baidao Industrial Co Ltd
HKEX:2555
|
CN |
|
Nissin Foods Co Ltd
HKEX:1475
|
HK |
|
Tivoli A/S
CSE:TIV
|
DK |
|
Carlsberg A/S
CSE:CARL B
|
DK |
|
ALM. Brand A/S
CSE:ALMB
|
DK |
|
M
|
Moneyboxx Finance Ltd
BSE:538446
|
IN |
|
Sekuro Plastik Ambalaj Sanayi AS
IST:SEKUR.E
|
TR |
|
Adeia Inc
NASDAQ:ADEA
|
US |
|
Confluent Inc
NASDAQ:CFLT
|
US |
|
Wei Chih Steel Industrial Co Ltd
TWSE:2028
|
TW |
|
Talgo SA
MAD:TLGO
|
ES |
|
DXP Enterprises Inc
NASDAQ:DXPE
|
US |
|
W
|
Wagend Infra Venture Ltd
BSE:503675
|
IN |
|
S
|
Shri Gang Industries and Allied Products Ltd
BSE:523309
|
IN |
|
S
|
Syensqo SA
XBRU:SYENS
|
BE |
|
P
|
Prince Pipes and Fittings Ltd
BSE:542907
|
IN |
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
|
Tetamat Gida Yatirimlari AS
IST:TETMT.E
|
TR |
|
Core & Main Inc
NYSE:CNM
|
US |
Multiples-Based Value
The Multiples-Based Value of one
SGRL
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 475.2 INR,
Shree Ganesh Remedies Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SGRL Multiples-Based Value
LOCKED
Multiples Across Competitors
SGRL Competitors Multiples
Shree Ganesh Remedies Ltd Competitors
Shree Ganesh Remedies Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Shree Ganesh Remedies Ltd
BSE:540737
|
6.1B INR | 6 | 33.6 | 18 | 25.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.6 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.2 | 21.6 | 15 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.3 | 30.3 | 16.7 | 23.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.2 | 20.9 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 20.4 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
